Published in ACS Chem Biol on March 29, 2013
trans-Cyclooctene--a stable, voracious dienophile for bioorthogonal labeling. Curr Opin Chem Biol (2013) 1.25
Beyond D-luciferin: expanding the scope of bioluminescence imaging in vivo. Curr Opin Chem Biol (2014) 1.17
A biocompatible "split luciferin" reaction and its application for non-invasive bioluminescent imaging of protease activity in living animals. Curr Protoc Chem Biol (2014) 0.80
Development of a Bioluminescent Nitroreductase Probe for Preclinical Imaging. PLoS One (2015) 0.78
Small Molecule Active Site Directed Tools for Studying Human Caspases. Chem Rev (2015) 0.77
In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease. Proc Natl Acad Sci U S A (2016) 0.75
Economical and scalable synthesis of 6-amino-2-cyanobenzothiazole. Beilstein J Org Chem (2016) 0.75
Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev (2003) 11.29
Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew Chem Int Ed Engl (2009) 8.15
Cell surface engineering by a modified Staudinger reaction. Science (2000) 8.09
Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science (2006) 6.55
Visualizing metabolically labeled glycoconjugates of living cells by copper-free and fast huisgen cycloadditions. Angew Chem Int Ed Engl (2008) 5.90
Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity. J Am Chem Soc (2008) 5.52
Chemical remodelling of cell surfaces in living animals. Nature (2004) 4.86
Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A (2003) 4.41
A comparative study of bioorthogonal reactions with azides. ACS Chem Biol (2006) 4.26
Tetrazine-based cycloadditions: application to pretargeted live cell imaging. Bioconjug Chem (2008) 3.93
Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol (1997) 3.47
Automated synthesis of peptides. Science (1965) 3.17
Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol (1999) 3.15
Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging. Phys Med Biol (2005) 3.11
An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry (2001) 3.05
Copper-free click chemistry in living animals. Proc Natl Acad Sci U S A (2010) 2.76
Rapid Cu-free click chemistry with readily synthesized biarylazacyclooctynones. J Am Chem Soc (2010) 2.74
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med (2001) 2.66
Real-time imaging of ligand-induced IKK activation in intact cells and in living mice. Nat Methods (2005) 2.22
Mechanistic investigation of the staudinger ligation. J Am Chem Soc (2005) 2.19
Genetic Encoding of bicyclononynes and trans-cyclooctenes for site-specific protein labeling in vitro and in live mammalian cells via rapid fluorogenic Diels-Alder reactions. J Am Chem Soc (2012) 2.03
Guided by the light: visualizing biomolecular processes in living animals with bioluminescence. Curr Opin Chem Biol (2009) 1.97
A "traceless" Staudinger ligation for the chemoselective synthesis of amide bonds. Org Lett (2000) 1.97
Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A (2002) 1.93
Caspases: preparation and characterization. Methods (1999) 1.92
The mitochondrial pathways of apoptosis. Adv Exp Med Biol (2012) 1.90
Probing mucin-type O-linked glycosylation in living animals. Proc Natl Acad Sci U S A (2006) 1.85
Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci U S A (2007) 1.81
A FRET-based fluorogenic phosphine for live-cell imaging with the Staudinger ligation. Angew Chem Int Ed Engl (2008) 1.79
Staudinger ligation: a peptide from a thioester and azide. Org Lett (2000) 1.77
Reactive polymer enables efficient in vivo bioorthogonal chemistry. Proc Natl Acad Sci U S A (2012) 1.74
Luciferin derivatives for enhanced in vitro and in vivo bioluminescence assays. Biochemistry (2006) 1.67
Imaging cell surface glycans with bioorthogonal chemical reporters. J Am Chem Soc (2007) 1.65
In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter. Proc Natl Acad Sci U S A (2010) 1.63
Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells. Clin Cancer Res (2005) 1.63
Bioluminescence imaging: progress and applications. Trends Biotechnol (2011) 1.59
Noninvasive bioluminescence imaging in small animals. ILAR J (2008) 1.59
Live-cell imaging of cyclopropene tags with fluorogenic tetrazine cycloadditions. Angew Chem Int Ed Engl (2012) 1.55
A biocompatible condensation reaction for controlled assembly of nanostructures in living cells. Nat Chem (2009) 1.54
Molecular transporters: synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging. Chembiochem (2006) 1.51
Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen. Cancer Res (1997) 1.51
Docetaxel: a review of its use in metastatic breast cancer. Drugs (2005) 1.47
Genetically encoded 1,2-aminothiols facilitate rapid and site-specific protein labeling via a bio-orthogonal cyanobenzothiazole condensation. J Am Chem Soc (2011) 1.42
Luminogenic cytochrome P450 assays. Expert Opin Drug Metab Toxicol (2006) 1.40
Luminescent imaging of beta-galactosidase activity in living subjects using sequential reporter-enzyme luminescence. Nat Methods (2006) 1.40
A biocompatible condensation reaction for the labeling of terminal cysteine residues on proteins. Angew Chem Int Ed Engl (2009) 1.36
Expedient synthesis of electronically modified luciferins for bioluminescence imaging. J Am Chem Soc (2012) 1.30
Difluorobenzocyclooctyne: synthesis, reactivity, and stabilization by beta-cyclodextrin. J Am Chem Soc (2010) 1.29
Mechanisms of bacterial pathogenicity. Postgrad Med J (2002) 1.29
Robust light emission from cyclic alkylaminoluciferin substrates for firefly luciferase. J Am Chem Soc (2010) 1.24
Structure, function and immunolocalization of a proton-coupled amino acid transporter (hPAT1) in the human intestinal cell line Caco-2. J Physiol (2003) 1.23
Releasable luciferin-transporter conjugates: tools for the real-time analysis of cellular uptake and release. J Am Chem Soc (2006) 1.23
Animal models of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.18
Strategies for in vivo imaging of enzyme activity: an overview and recent advances. Chem Soc Rev (2011) 1.18
Control and design of mutual orthogonality in bioorthogonal cycloadditions. J Am Chem Soc (2012) 1.14
In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis. Mol Ther (2005) 1.12
Bioluminescence imaging: looking beyond the light. Trends Mol Med (2012) 1.12
Monitoring caspase-3 activation with a multimodality imaging sensor in living subjects. Clin Cancer Res (2008) 1.10
Identification of mutant firefly luciferases that efficiently utilize aminoluciferins. Chem Biol (2011) 1.10
Development and evaluation of new cyclooctynes for cell surface glycan imaging in cancer cells. Chem Sci (2011) 1.08
N-Alkylated 6'-aminoluciferins are bioluminescent substrates for Ultra-Glo and QuantiLum luciferase: new potential scaffolds for bioluminescent assays. Biochemistry (2008) 1.07
Homogeneous, bioluminescent protease assays: caspase-3 as a model. J Biomol Screen (2005) 1.06
Real-time noninvasive imaging of fatty acid uptake in vivo. ACS Chem Biol (2012) 1.06
A generally applicable method for assessing the electrophilicity and reactivity of diverse nitrile-containing compounds. Bioorg Med Chem Lett (2006) 1.06
A selenium analogue of firefly D-luciferin with red-shifted bioluminescence emission. Angew Chem Int Ed Engl (2012) 1.06
Imaging sialylated tumor cell glycans in vivo. FASEB J (2011) 1.05
Cellular bioluminescence imaging. Cold Spring Harb Protoc (2012) 1.04
Bioluminescent imaging of TRAIL-induced apoptosis through detection of caspase activation following cleavage of DEVD-aminoluciferin. Cancer Biol Ther (2005) 1.04
A bioluminogenic substrate for in vivo imaging of beta-lactamase activity. Angew Chem Int Ed Engl (2007) 1.03
Staudinger ligation as a method for bioconjugation. Angew Chem Int Ed Engl (2011) 1.02
In vivo bioluminescence imaging of furin activity in breast cancer cells using bioluminogenic substrates. Bioconjug Chem (2009) 1.02
Zebrafish as a "biosensor"? Effects of ionizing radiation and amifostine on embryonic viability and development. Cancer Res (2006) 1.01
Controlling intracellular macrocyclization for the imaging of protease activity. Angew Chem Int Ed Engl (2011) 1.00
In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation. Apoptosis (2011) 0.99
A Pictet-Spengler ligation for protein chemical modification. Proc Natl Acad Sci U S A (2012) 0.99
Comparison of red-shifted firefly luciferase Ppy RE9 and conventional Luc2 as bioluminescence imaging reporter genes for in vivo imaging of stem cells. J Biomed Opt (2012) 0.99
Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate, Z-DEVD-aminoluciferin. Cell Death Differ (2010) 0.98
Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Circulation (2003) 0.97
Docetaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of metastatic breast cancer. Drugs (1996) 0.97
Molecular mechanisms of cystine transport. Biochem Soc Trans (2001) 0.96
Advancing molecular therapies through in vivo bioluminescent imaging. Mol Imaging (2003) 0.92
Real-time bioluminescence imaging of glycans on live cells. J Am Chem Soc (2010) 0.92
Kinetics of inhibition of firefly luciferase by dehydroluciferyl-coenzyme A, dehydroluciferin and L-luciferin. Photochem Photobiol Sci (2011) 0.92
Expression of apoptosis-related genes during human preimplantation embryo development: potential roles for the Harakiri gene product and Caspase-3 in blastomere fragmentation. Mol Hum Reprod (2003) 0.90
Animal modeling of cancer pathology and studying tumor response to therapy. Curr Drug Targets (2012) 0.90
Synthesis and characterization of a bioluminogenic substrate for alpha-chymotrypsin. Anal Biochem (1994) 0.89
Prostate cancer chemotherapy in the era of targeted therapy. Prostate Cancer Prostatic Dis (2008) 0.88
Electrophilic aromatic substituted luciferins as bioluminescent probes for glutathione S-transferase assays. Chem Commun (Camb) (2006) 0.87
New bioluminogenic substrates for monoamine oxidase assays. J Am Chem Soc (2006) 0.86
Cisplatin: a review of clinical applications and renal toxicity. Pharm Weekbl Sci (1985) 0.86
Fluorogenic peptide-based substrates for monitoring thrombin activity. ChemMedChem (2012) 0.86
Bioluminescence based in vivo screening technologies. Curr Opin Pharmacol (2012) 0.86
Automated peptide synthesis. Nature (1965) 0.84
Characterization of multiple cysteine and cystine transporters in rat alveolar type II cells. Am J Physiol (1997) 0.84
Dentatorubral pallidoluysian atrophy (DRPLA) protein is cleaved by caspase-3 during apoptosis. J Biol Chem (1997) 0.84
Cerebrovascular protection of β-asarone in Alzheimer's disease rats: a behavioral, cerebral blood flow, biochemical and genic study. J Ethnopharmacol (2012) 0.82
Blunting nature's Swiss army knife. Science (1997) 0.81
Labor-effective manipulation of marine and beetle luciferases for bioassays. Protein Eng Des Sel (2012) 0.81
Carvacrol together with TRPC1 elimination improve functional recovery after traumatic brain injury in mice. J Neurotrauma (2012) 0.81
Gastric Helicobacter spp. in animal models: pathogenesis and modulation by extragastric coinfections. Methods Mol Biol (2012) 0.78
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell (2009) 16.06
Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer (2008) 15.20
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet (2012) 9.86
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell (2005) 9.18
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest (2003) 8.34
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. Cancer Cell (2010) 6.33
A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med (2013) 6.09
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A (2006) 5.90
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev (2006) 5.53
Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A (2006) 4.51
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell (2004) 4.38
GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev (2009) 4.21
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med (2011) 4.10
Role of nucleophosmin in embryonic development and tumorigenesis. Nature (2005) 4.09
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest (2004) 4.03
Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell (2009) 4.02
Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol (2012) 3.48
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J Clin Invest (2010) 3.47
A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. J Clin Oncol (2004) 3.40
Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Proc Natl Acad Sci U S A (2004) 3.40
Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc (2009) 3.31
VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis. Cancer Cell (2002) 3.27
Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity. Inflamm Bowel Dis (2014) 3.22
Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy. Proc Natl Acad Sci U S A (2010) 3.16
Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum. Nat Chem Biol (2008) 3.16
Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell (2002) 3.02
Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nat Chem Biol (2005) 2.90
Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One (2009) 2.89
Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat Chem Biol (2007) 2.80
Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev (2006) 2.74
Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res (2002) 2.69
Acupuncture for peripheral joint osteoarthritis. Cochrane Database Syst Rev (2010) 2.57
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell (2003) 2.56
A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell (2004) 2.44
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev (2009) 2.41
Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med (2008) 2.40
Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation (2011) 2.29
Activity-based probes that target diverse cysteine protease families. Nat Chem Biol (2005) 2.21
Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res (2006) 2.20
A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science (2002) 2.20
Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2012) 2.19
A killer-protector system regulates both hybrid sterility and segregation distortion in rice. Science (2012) 2.16
Endogenous Myc maintains the tumor microenvironment. Genes Dev (2011) 2.16
Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J Clin Invest (2004) 2.12
Of mice and MEN1: Insulinomas in a conditional mouse knockout. Mol Cell Biol (2003) 2.12
Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells (2010) 2.10
Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase. Cancer Cell (2013) 2.09
Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J Lipid Res (2004) 2.08
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell (2003) 2.07
Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities. J Biol Chem (2006) 2.05
Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol Med (2013) 2.04
Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A. Blood (2011) 2.02
Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J Exp Med (2011) 1.93
Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nat Med (2009) 1.90
Dedifferentiation and proliferation of mammalian cardiomyocytes. PLoS One (2010) 1.89
Brivanib, a dual FGF/VEGF inhibitor, is active both first and second line against mouse pancreatic neuroendocrine tumors developing adaptive/evasive resistance to VEGF inhibition. Clin Cancer Res (2011) 1.85
Immune enhancement of skin carcinogenesis by CD4+ T cells. J Exp Med (2003) 1.84
Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc Natl Acad Sci U S A (2003) 1.83
Chemical approaches for functionally probing the proteome. Mol Cell Proteomics (2002) 1.78
Acupuncture for irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol (2012) 1.76
A triallelic system of S5 is a major regulator of the reproductive barrier and compatibility of indica-japonica hybrids in rice. Proc Natl Acad Sci U S A (2008) 1.71
Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. Neoplasia (2008) 1.70
Tagging and detection strategies for activity-based proteomics. Curr Opin Chem Biol (2006) 1.70
FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol Cell Biol (2006) 1.70
Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain. Science (2008) 1.67
Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide. Blood (2012) 1.66
Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Blood (2011) 1.66
In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter. Proc Natl Acad Sci U S A (2010) 1.63
5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci Transl Med (2011) 1.63
Rational design of inhibitors and activity-based probes targeting Clostridium difficile virulence factor TcdB. Chem Biol (2010) 1.60
Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction. Circulation (2013) 1.51
Rab35 controls actin bundling by recruiting fascin as an effector protein. Science (2009) 1.51
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. Blood (2011) 1.51
Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr (2011) 1.50
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse. Blood (2008) 1.50
Protein-mediated fatty acid uptake: novel insights from in vivo models. Physiology (Bethesda) (2006) 1.48
Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J Biol Chem (2003) 1.46
Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. Gastroenterology (2006) 1.45
Activity-based protein profiling: applications to biomarker discovery, in vivo imaging and drug discovery. Am J Pharmacogenomics (2004) 1.45
A substrate-inspired probe monitors translocation, activation, and subcellular targeting of bacterial type III effector protease AvrPphB. Chem Biol (2013) 1.44
CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer. Cancer Res (2005) 1.44
Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Mol Cell (2006) 1.43
A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene (2005) 1.43
Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. Chem Biol (2002) 1.42
Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repair. Cardiovasc Res (2010) 1.41
Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nat Nanotechnol (2011) 1.41
Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency. J Clin Invest (2017) 1.39
Mechanistic and structural insights into the proteolytic activation of Vibrio cholerae MARTX toxin. Nat Chem Biol (2009) 1.36
Activity profiling of papain-like cysteine proteases in plants. Plant Physiol (2004) 1.36
Multiple roles for cysteine cathepsins in cancer. Cell Cycle (2004) 1.36
Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation. Exp Cell Res (2009) 1.35
Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell (2010) 1.35
Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis. Mol Cell Biol (2004) 1.34
Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase. Mol Biochem Parasitol (2003) 1.34
A mild chemically cleavable linker system for functional proteomic applications. Angew Chem Int Ed Engl (2007) 1.33
Aminopeptidase fingerprints, an integrated approach for identification of good substrates and optimal inhibitors. J Biol Chem (2009) 1.33
Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia. J Biol Chem (2008) 1.32
VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res (2009) 1.32